In connection with the implementation of the project entitled “Development and development of an innovative solution – a generic drug from the group of GLP-1 receptor agonists in the treatment of type 2 diabetes” financed from the state budget by the Medical Research Agency, Polpharma S.A. Pharmaceutical Works is asking for tenders for the provision of services in the field of analytical research.
Details of the price inquiry can be found in the attached documents.